Thermo Fisher Scientific (TMO) said late Thursday its board authorized the repurchase of up to $5 billion of common shares, replacing an existing buyback authorization.

The company also maintained its quarterly dividend at $0.47 per share, payable Jan. 15, 2027, to stockholders of record Dec. 15.